The liver panel — sometimes called liver function tests, liver enzymes, or LFTs — is a group of blood tests used to assess how well your liver is working and whether the liver is injured or inflamed. The tests in a liver panel overlap substantially with those in a comprehensive metabolic panel (CMP), but a dedicated liver panel often includes additional tests that provide more detail on specific aspects of liver health.
This article explains what each test in a liver panel measures, what abnormal results may mean, and how the results are interpreted together to identify patterns of liver disease.
The reference range that applies to your result is the one printed on your laboratory report, not the typical ranges shown here. Reference ranges vary between laboratories based on the equipment used, the population tested, and individual factors such as age, sex, and pregnancy status. Always compare your result to the reference range printed on your own report, and discuss any abnormal result with your doctor.
What does the liver do?
The liver is the largest internal organ in the body and one of the most metabolically active. It carries out hundreds of functions, including:
- Filtering toxins and waste from the blood, including alcohol and most medications
- Producing bile, a fluid that helps digest fats in the small intestine
- Producing proteins such as albumin, clotting factors, and many hormones
- Storing and releasing glucose to help maintain steady blood sugar
- Storing vitamins, including vitamin A, vitamin D, vitamin B12, and iron
- Processing nutrients absorbed from food
Because the liver does so many different jobs, no single blood test gives a complete picture of liver health. Instead, the liver panel measures several markers, each reflecting a different aspect of liver function or injury.
What is a liver panel?
The exact tests in a liver panel vary between laboratories and clinical situations, but most include some combination of the following:
- Alanine aminotransferase (ALT) — an enzyme released when liver cells are injured
- Aspartate aminotransferase (AST) — another enzyme released by liver injury, also found in heart and muscle
- Alkaline phosphatase (ALP) — an enzyme that rises with bile duct problems and bone disease
- Gamma-glutamyl transferase (GGT) — an enzyme that rises with liver and bile duct problems but not bone disease
- Lactate dehydrogenase (LDH) — an enzyme found throughout the body, including the liver
- Total bilirubin — a waste product processed by the liver
- Albumin — the most abundant protein made by the liver
- Total protein — the combined amount of albumin and globulin
- Prothrombin time (PT) — a measure of blood clotting that depends on liver-made clotting factors
The first six items overlap with the CMP. Our CMP article covers ALT, AST, ALP, total bilirubin, albumin, and total protein in detail. This article focuses primarily on the additional tests — GGT, LDH, and PT — and on how to interpret them together.
Why is a liver panel done?
A liver panel is ordered for many reasons, including:
- To investigate symptoms. Jaundice (yellowing of skin or eyes), abdominal pain, nausea, fatigue, dark urine, pale stools, or unexplained weight loss may all prompt a liver panel.
- To follow up on an abnormal CMP. If liver-related tests on a CMP are abnormal, a more complete liver panel — often including GGT and PT — is often the next step.
- To screen for liver disease. Risk factors for liver disease include heavy alcohol use, obesity, type 2 diabetes, viral hepatitis exposure, family history of liver disease, and use of certain medications.
- To monitor known liver disease. Patients with chronic hepatitis, fatty liver disease, cirrhosis, or autoimmune liver disease have liver panels done regularly.
- To monitor medications. Many medications — including statins, methotrexate, anti-tuberculosis drugs, anti-seizure medications, and chemotherapy — can affect the liver, and liver panels are used to monitor their effects.
- Before surgery and during hospitalization. Liver function affects clotting, drug metabolism, and recovery, so liver panels are often part of pre-operative and inpatient testing.
How is the test performed?
A liver panel is performed on a small blood sample, usually drawn from a vein in the arm. No fasting is required for most liver tests. Some doctors prefer a fasting sample to avoid mild elevations that can occur after eating a heavy meal, but this varies. Results are usually available within a few hours.
The additional liver panel tests
Gamma-glutamyl transferase (GGT)
Gamma-glutamyl transferase is an enzyme produced by the liver and bile ducts. It is one of the most sensitive tests for liver injury and bile duct problems, but it is not very specific — many things can raise GGT.
A typical reference range for adults is 8–61 U/L, with men generally having higher values than women.
The most useful role of GGT is in distinguishing between liver and non-liver causes of an elevated alkaline phosphatase. ALP rises with both liver and bone problems. GGT rises with liver and bile duct problems but does not rise with bone disease. So when ALP is elevated:
- If GGT is also elevated, the source is most likely liver or bile ducts.
- If GGT is normal, the elevated ALP is more likely from bone or another non-liver source.
Causes of high GGT:
- Bile duct obstruction (gallstones, tumours, or strictures)
- Alcohol use, even at moderate levels — GGT is one of the most sensitive markers of recent alcohol use and is often used to monitor abstinence
- Fatty liver disease
- Viral hepatitis
- Cirrhosis
- Certain medications, including phenytoin, carbamazepine, and barbiturates
- Heart failure (a mild rise)
GGT is rarely low in a clinically significant way.
Lactate dehydrogenase (LDH)
Lactate dehydrogenase is an enzyme used by cells throughout the body to produce energy. It is found in the liver, lungs, kidneys, blood cells, heart, and muscles. Because LDH is so widespread, an elevated level indicates that cells somewhere in the body are being damaged or destroyed, but it does not specify where.
A typical reference range for adults is approximately 122–222 U/L.
Causes of high LDH:
- Liver disease, including hepatitis and cirrhosis
- Hemolysis (rapid breakdown of red blood cells)
- Heart attack and other heart muscle injury (although troponin is now the preferred cardiac test)
- Skeletal muscle injury
- Pulmonary embolism (blood clot in the lung)
- Some cancers, including lymphoma and germ cell tumours, where LDH is sometimes used as a marker of disease activity
- Severe infections
Causes of low LDH are rare and not usually clinically significant.
LDH on its own is rarely diagnostic. It is most useful when interpreted alongside more specific tests.
Prothrombin time (PT) and INR
Prothrombin time measures how long it takes the blood to form a clot. The test is performed by adding specific chemicals to a blood sample and timing how quickly clotting occurs. Most of the proteins involved in this clotting process are made by the liver, so when liver function is impaired, the PT becomes prolonged.
A typical reference range for adults is approximately 11–13.5 seconds, though laboratories vary and the test is often reported alongside an international normalized ratio (INR). The INR adjusts the result for laboratory differences and allows comparison across labs. A typical INR for someone who is not taking blood thinners is 0.8–1.2.
Causes of a prolonged PT or elevated INR:
- Severe liver disease, particularly cirrhosis or acute liver failure, a prolonged PT is one of the most important markers of poor liver function
- Vitamin K deficiency, which can occur in malabsorption, prolonged antibiotic use, or poor nutrition
- Warfarin and other vitamin K antagonist anticoagulants
- Disseminated intravascular coagulation (DIC), a serious clotting disorder
- Inherited clotting factor deficiencies
The PT and INR are particularly important because, unlike the liver enzymes (ALT, AST, ALP, GGT, LDH), they reflect the liver’s actual functional capacity rather than just liver injury. Liver enzymes can be very high in a patient whose liver is still working well, while a prolonged PT in a patient with chronic liver disease is a warning sign of significant loss of liver function.
For a more detailed discussion of clotting tests including PTT, see our Understanding your coagulation panel article.
Putting the liver panel together
Each test in the liver panel reflects a different aspect of liver health. The most useful information often comes from looking at the panel as a whole rather than at individual tests.
Tests of liver injury versus liver function
It is helpful to divide the liver tests into two broad categories:
- Tests of liver injury — including ALT, AST, ALP, GGT, and LDH. These rise when liver cells are damaged or when the bile ducts are blocked. They tell you that something is wrong but don’t directly tell you how well the remaining liver tissue is working.
- Tests of liver function — including albumin, total bilirubin, and PT/INR. These reflect the liver’s actual working capacity. They tell you whether the liver is keeping up with its responsibilities.
It is possible to have very abnormal injury markers with normal function markers (for example, in early acute viral hepatitis), or near-normal injury markers with abnormal function markers (for example, in advanced cirrhosis). The combination of patterns provides much more information than any single test.
Three patterns of liver test abnormalities
- Hepatocellular pattern. ALT and AST are elevated, with ALP and bilirubin normal or only mildly elevated. This pattern points to direct injury of liver cells. Causes include viral hepatitis, fatty liver disease, alcohol-related liver injury, and medication toxicity. Sudden very high ALT (sometimes more than 1000 U/L) suggests acute hepatitis, drug toxicity, or severe liver injury.
- Cholestatic pattern. ALP and bilirubin are elevated, with ALT and AST normal or only mildly elevated. GGT is also typically elevated, confirming the liver source. This pattern points to bile flow problems and suggests causes such as bile duct obstruction (often gallstones), primary biliary cholangitis, or certain medication reactions.
- Mixed pattern. Both groups are elevated. This is non-specific and may need additional investigation.
The AST:ALT ratio
The relative levels of AST and ALT can suggest specific causes:
- An AST:ALT ratio greater than 2 in someone with elevated liver enzymes is a classic sign of alcohol-related liver disease.
- An AST:ALT ratio less than 1 (ALT higher than AST) is more typical of viral hepatitis or fatty liver disease.
- A very high AST without elevated ALT may suggest a non-liver source such as muscle injury or hemolysis.
Magnitude matters
How high the liver enzymes rise is also informative:
- Mildly elevated liver enzymes (less than 2–3 times the upper limit of normal) are common, often non-specific, and may resolve on their own. Common causes include fatty liver disease, alcohol, medications, and viral infections.
- Moderately elevated liver enzymes (3–10 times normal) are more specific and often warrant additional workup.
- Severely elevated liver enzymes (more than 10 times normal, or above 1,000 U/L) usually point to a more limited list of causes — acute viral hepatitis, drug toxicity (especially acetaminophen overdose), severe liver ischemia, or autoimmune hepatitis flare — and typically prompt urgent evaluation.
What happens after a liver panel?
If your liver panel results are within reference ranges, no further investigation is usually needed. If results are abnormal, the next steps depend on the pattern, magnitude, and your overall clinical picture. Some common next steps include:
- Repeat the test. Mildly abnormal liver enzymes often resolve on their own. A repeat test in 2–4 weeks can confirm whether the abnormality is real and persistent.
- Hepatitis testing. Persistently elevated liver enzymes typically prompt testing for hepatitis B and hepatitis C, and sometimes hepatitis A.
- Iron studies. An elevated ferritin may prompt testing for hemochromatosis, an inherited condition causing iron overload.
- Autoimmune liver tests. Persistent unexplained elevations may prompt testing for autoimmune hepatitis (ANA, anti-smooth muscle antibody) or primary biliary cholangitis (anti-mitochondrial antibody).
- Imaging. Abdominal ultrasound is the usual first imaging test and can identify fatty liver, gallstones, bile duct obstruction, and liver tumours. CT or MRI may follow if more detail is needed.
- Review of medications and alcohol. Your doctor may ask about all medications, supplements, and alcohol use, and may stop or change suspected agents to see if liver tests improve.
- Referral to a specialist. Persistent or significant abnormalities may prompt referral to a hepatologist or gastroenterologist.
- Liver biopsy. In some cases, a liver biopsy may be needed to determine the cause and severity of liver disease when blood tests and imaging cannot.
Liver test abnormalities are common and often have benign explanations, but they should not be ignored. Persistent abnormalities, even mild ones, deserve a thoughtful workup to identify the cause.
Questions to ask your doctor
- Were any of my liver test results outside the reference range?
- What pattern do my liver tests show — hepatocellular, cholestatic, or mixed?
- How significant is the elevation, and what are the most likely causes?
- Could any of my medications, supplements, or alcohol intake be contributing?
- Should the test be repeated, and if so, when?
- Do I need testing for hepatitis B or C, autoimmune liver disease, or hemochromatosis?
- Should I have an abdominal ultrasound or other imaging?
- Are there changes I can make to my diet, weight, alcohol use, or medications that would improve my results?
- Should I be referred to a hepatologist or gastroenterologist?
Related articles on MyPathologyReport.com